GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qrons Inc (OTCPK:QRON) » Definitions » Net Policyholder Benefits/Claims

Qrons (QRON) Net Policyholder Benefits/Claims


View and export this data going back to 2017. Start your Free Trial

What is Qrons Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Qrons Business Description

Industry
Traded in Other Exchanges
N/A
Address
611 N. Brand Boulevard, Suite 1300, Glendale, CA, USA, 91203
Qrons Inc. is a biotechnology company, dedicated to developing biotech products, treatments, and technologies to combat neuronal and infectious diseases with a focus on antibiotic-resistant bacteria, which is becoming the prominent and rapidly growing world-wide cause of illness and death. The technology would treat a wide range of neurodegenerative diseases. The treatment integrates proprietary, engineered mesenchymal stem cells, 3D printable scaffolding, smart materials, and a novel delivery system. The company has two product candidates, QS100TM for treating penetrating brain injuries and QS200TM for treating concussions and other diffused axonal injuries.
Executives
John N Bonfiglio officer: Chief Operating Officer C/O MICROLIN BIO, INC., NEW YORK NY 10022
Jonah Meer director, 10 percent owner, officer: CEO, CFO and Secretary 28-10 JACKSON AVENUE, #26N, LONG ISLAND CITY NY 11101
Ido Merfeld director, 10 percent owner, officer: President 153 HAGILBOA STREET, NIRIT L3 44805